Mood and behavioural effects of subthalamic stimulation in Parkinson's disease (Q38189892)

30 August 2017

1 reference

title

Mood and behavioural effects of subthalamic stimulation in Parkinson's disease (English)

1 reference

30 August 2017

1 reference

4

Paul Krack

1 reference

30 August 2017

3

Elena Moro

1 reference

30 August 2017

Anna Castrioto

1

1 reference

PubMed ID

24556007

30 August 2017

Eugénie Lhommée

series ordinal

2

1 reference

30 August 2017

17 February 2014

1 reference

30 August 2017

1 reference

30 August 2017

13

1 reference

30 August 2017

3

1 reference

30 August 2017

287-305

1 reference

Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Latest view on the mechanism of action of deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Postoperative management of deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

[Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Functional anatomy of the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

1 reference

7 January 2021

Mirthful laughter induced by subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Modeling the organization of the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for Basal Ganglia models and deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The corticostriatal and corticosubthalamic pathways: two entries, one target. So what?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Inhibition of ongoing responses in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Aggressive behavior induced by intraoperative stimulation in the triangle of Sano.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Risky choices link the subthalamic nucleus with pathological gambling in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Film excerpts shown to specifically elicit various affects lead to overlapping activation foci in a large set of symmetrical brain regions in males

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The neural correlates of maternal and romantic love

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Chronic but not acute dopaminergic transmission interruption promotes a progressive increase in cortical beta frequency synchronization: relationships to vigilance state and akinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

New insights into the relationship between dopamine, beta oscillations and motor function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Self-paced movements induce high-frequency gamma oscillations in primary motor cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Basal ganglia local field potential activity: character and functional significance in the human

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Cognitive factors modulate activity within the human subthalamic nucleus during voluntary movement in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Activation of the subthalamic region during emotional processing in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Asymmetric right/left encoding of emotions in the human subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Beta-band oscillations--signalling the status quo?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

A role for the subthalamic nucleus in response inhibition during conflict

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep brain stimulation: from neurology to psychiatry?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Cognitive and limbic effects of deep brain stimulation in preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Psychiatric considerations in deep brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Psychostimulant effect of levodopa: reversing sensitisation is possible

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Short- and long-duration responses to levodopa during the first year of levodopa therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Levodopa and the progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Mania following deep brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: clinical, anatomical and functional imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

1 reference

7 January 2021

Transient acute depressive state induced by subthalamic region stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Medial forebrain bundle stimulation as a pathophysiological mechanism for hypomania in subthalamic nucleus deep brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Explosive-aggressive behavior related to bilateral subthalamic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Long-term outcomes of surgical therapies for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The impact of deep brain stimulation on executive function in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Stimulation of contacts in ventral but not dorsal subthalamic nucleus normalizes response switching in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep brain stimulation (DBS) attentional effects parallel those of l-dopa treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Neural correlates of STN DBS-induced cognitive variability in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus influences spatial orientation in extra-personal space.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

STN stimulation alters pallidal-frontal coupling during response selection under competition.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus stimulation affects a frontotemporal network: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Stimulation of STN impairs aspects of cognitive control in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effects of subthalamic deep brain stimulation on noun/verb generation and selection from competing alternatives in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Stimulation of the subthalamic nucleus and impulsivity: release your horses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Reduction of influence of task difficulty on perceptual decision making by STN deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Stimulation of subthalamic nucleus inhibits emotional activation of fusiform gyrus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Lexical-semantic inhibitory mechanisms in Parkinson's disease as a function of subthalamic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effects of subthalamic nucleus stimulation on emotional prosody comprehension in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Facial expression recognition and subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Neurostimulation for Parkinson's Disease with Early Motor Complications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

A randomized trial of deep-brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Suicide after successful deep brain stimulation for movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Suicide after deep brain stimulation of the internal globus pallidus for dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Dopamine agonist withdrawal syndrome in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Nonmotor fluctuations in Parkinson's disease: frequent and disabling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effect of subthalamic deep brain stimulation on non-motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effect of subthalamic deep brain stimulation on pain in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Bilateral STN-DBS fails to improve non-motor fluctuations in a PD patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Behavioural disorders, Parkinson's disease and subthalamic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Body weight gain rate in patients with Parkinson's disease and deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Obesity in Parkinson's disease patients on electrotherapy: collateral damage, adiposity rebound or secular trends?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Depressive state, aging, and prevalence of snacking: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Improvement of sleep architecture in PD with subthalamic nucleus stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The epidemiology of dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Apathy may herald cognitive decline and dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Long-term results of bilateral pallidal stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Deep brain stimulation in Parkinson's disease: reconciliation of evidence-based medicine with clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Randomized trial of pallidotomy versus medical therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Parkinson disease: deep brain stimulation in Parkinson disease-what went wrong?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

1 reference

7 January 2021

Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

Different populations of subthalamic neurons encode cocaine vs. sucrose reward and predict future error

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970294-1

7 January 2021

10.1016/S1474-4422(13)70294-1

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24556007